Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Atara Biotherapeutics Stock Is Crashing Today

TheMotleyFool

0 0

Shares of the next-generation cell therapy company Atara Biotherapeutics (NASDAQ: ATRA) are getting hammered today. Specifically, the clinical-stage biotech's stock was down by an unsightly 54% as of 3:36 p.m. ET Wednesday.

What's weighing on Atara's share price today? Prior to Wednesday's opening bell, Atara announced that the closely watched multiple sclerosis candidate, known as ATA188, will continue its ongoing phase 2 trial without any changes.

Image source: Getty Images.

Source Fool.com

Like: 0

ATRA

Share